0001615898-21-000001.txt : 20210302 0001615898-21-000001.hdr.sgml : 20210302 20210302160920 ACCESSION NUMBER: 0001615898-21-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210302 DATE AS OF CHANGE: 20210302 EFFECTIVENESS DATE: 20210302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pear Therapeutics, Inc. CENTRAL INDEX KEY: 0001615898 IRS NUMBER: 463597074 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-383679 FILM NUMBER: 21703614 BUSINESS ADDRESS: STREET 1: 200 STATE STREET, 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6469322774 MAIL ADDRESS: STREET 1: 200 STATE STREET, 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 D/A 1 primary_doc.xml X0708 D/A LIVE 0001615898 Pear Therapeutics, Inc. 200 STATE STREET, 13TH FLOOR BOSTON MA MASSACHUSETTS 02109 6469322774 DELAWARE None None Corporation true Corey McCann c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Director Andrew Schwab c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Director Zack Lynch c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Director Timothy Petersen c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Director Elena Viboch c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Director Ms. Viboch was elected as a Director subsequent to the Date of First Sale. Nancy Schlichting c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Director Ms. Schlichting was elected as a Director subsequent to the Date of First Sale. Christopher Guiffre c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Julia Strandberg c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Yuri Maricich c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Ronan O'Brien c/o Pear Therapeutics 200 State Street, 13th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Other Health Care Decline to Disclose 06b true 0001615898-20-000002 2020-12-07 false true false 0 131999923 131999923 0 Includes $31,999,996 of proceeds used to repurchase securities, resulting in $99,999,927 of gross proceeds after the repurchase (before expenses). false 22 0 0 0 false Pear Therapeutics, Inc. /s/ Christopher Guiffre Christopher Guiffre CFO & COO 2021-03-02